Onconova appoints James Marino board
This article was originally published in Scrip
Executive Summary
Newtown, Pennsylvania-based Onconova Therapeutics, a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, has named James J Marino to its board of directors. Mr Marino was a partner at the global law firm of Dechert for 28 years where he was managing partner of the Princeton office. During this period, he advised numerous leading life science companies in connection with financings, acquisitions and strategic alliances. He served as the outside counsel for Onconova from its inception through and including its initial public offering. Previously, he was on the board of Pharmacopeia Drug Discovery from 2000-2006 and has worked in advisory capacities and on the boards of multiple non-profit organizations, including Robert Wood Johnson University Hospital.